VAL / Applied Intelligence SystemsData · Models · Agents · Orchestration

Orchestrating intelligence
across complex systems.

VAL combines data science, models, agents, and orchestration to support complex decisions and workflows, with evidence, controls, and human authority built in.

Explore the systems

Project 01 / Group Risk Pricing

CMS synthetic claims · model evaluation
Public synthetic data

CMS synthetic group simulation

Forecast next-period claims cost. Measure every error.

Target Group PMPM

Research groups

10,225Stratified synthetic cohorts

Holdout groups

2,045Unseen during training

Members / group

150-300Large-group simulation

Total error

−23.2%vs. actuarial baseline

Prediction error index

Actuarial baseline = 100 · lower is better
Holdout benchmark
Actuarial baselineReference process
100
Linear regression19.0% lower error
80.9
Gradient boost23.2% lower error
77.7

Selected model

Gradient-boosted regression
Validated
77.7ERROR INDEX
TrainCompareSelect
Run parameters and results retained

Research benchmark on CMS synthetic public-use claims. Figures describe a historical simulation, not production performance or a member-level clinical decision.

01Risk pricing / The decision

Group healthcare risk

Price tomorrow’s risk from the evidence available today.

Large-group pricing begins with an uncertain future claim cost. VAL turns prior membership, claims, and diagnostic history into a group-level forecast expressed in per-member-per-month terms.

01Membership
02Claims history
03ICD-10
04CCSR + chronicity
05Group features
06PMPM forecast
Public-data research foundation

The original model work uses CMS Medicare DE-SynPUF: realistic-but-synthetic claims created for software development and research training while protecting beneficiary privacy.

01.1Risk pricing / The system

Claims become model-ready evidence

The model starts before model training.

Raw claims are standardized, clinically grouped, separated into acute and chronic signals, and shaped into a reproducible feature table. Every run carries the choices that created it.

Implemented research pipeline
Run / Group PMPM
Evidence chain complete
01 / StandardizeClaims + membership

Common fields, exposure, service categories, and paid amounts

02 / ClassifyICD-10 → CCSR

Diagnosis chapters, clinical categories, acute and chronic views

03 / TrainCompeting regressors

Candidate models and parameter combinations evaluated on held-out groups

04 / SelectLowest measured error

Best-fit model selected for the defined cohort and target

Run policy

Outlier threshold, feature percentile, chronicity view, and pooling treatment remain explicit - not hidden inside the forecast.

Reviewable
01.2Risk pricing / The evidence

A benchmark, not a promise

Accuracy is only useful when the comparison is visible.

The research archive tests forecasts against held-out outcomes and a reconstructed actuarial baseline. The result is a measurable error distribution - not a black-box confidence claim.

Fig. 01 / Model comparisonNormalized total forecast error
Actuarial baselineReference process
100
Linear regression19.0% lower error
80.9
Gradient boost23.2% lower error
77.7

In the archived holdout simulation, gradient boosting reduced total forecast error by 23.2% relative to the actuarial baseline. Linear regression reduced it by 19.0%.

Fig. 02 / Cost concentrationDiagnosis chapters carry unequal signal
01Circulatory
19%
02Musculoskeletal
10%
03Health-status factors
10%
04Respiratory
8%
05Neoplasms
8%

The leading diagnosis chapters account for roughly half of paid claim cost in the source analysis. Feature selection preserves the most consequential signals while controlling dimensionality.

Research boundary. CMS states that DE-SynPUF has limited inferential value for conclusions about Medicare beneficiaries. VAL uses it here to develop and test analytical software, data structures, and model-evaluation methods.

CMS source
02Project / Agent workforce

Controlled claims operations

Specialized agents work the claim. A supervisor owns the decision.

A synthetic claim is divided into document, clinical, policy, control, adjudication, and settlement tasks. The orchestrator can advance it only when every mandatory review passes; ambiguity, conflict, or low confidence stops the workflow for human review.

Claims operations / Supervisor viewAll records and people are synthetic

Claim / CLM-2841

Outpatient surgical claim

Human review required
Submitted$18,460.00Member matchConfirmedCoverageActiveServiceOutpatient
ORCH-01
Atlas

Coordination

Reconciling
DOC-02
Lens

Document extraction

Complete
CLN-03
Axiom

Clinical review

Exception
POL-04
Pact

Coverage + policy

Complete
CTL-05
Sentry

Fraud + controls

Complete
ADJ-06
Ledger

Adjudication

Blocked
Clinical documentation / EX-014Authorization reference is missing from the submitted record.

Axiom found support for the procedure, but could not reconcile the required authorization. Automatic adjudication is blocked until a supervisor resolves the exception.

14 controls passed 1 material exception Audit trail current Human authority retained

Concept prototype using original agent identities and synthetic records. Payment is simulated; no external claim, clinical, or financial system is connected.

03Shared infrastructure

Designed for underwriting review

A forecast enters the process. It does not replace the process.

01

Fixed data contract

The same required group, exposure, target, and feature fields across every modelling run.

02

Run lineage

Dataset, parameters, candidate models, validation metrics, and selected model stay connected.

03

Error visibility

Under- and over-estimation remain visible across the full book and high-cost segments.

04

Human authority

Actuarial and underwriting judgement can review, challenge, adjust, or reject the output.

Lab / Five live experiments

Risk in Motion

A separate visual laboratory for signal, prediction, anomaly, and control. The cars live here; the healthcare system stays grounded in healthcare evidence.

Enter the lab
04Working principles
01

Measure the comparison

Model quality is evaluated against held-out outcomes and the pricing process it is intended to improve.

02

Expose the assumptions

Feature selection, outlier handling, pooling, and cohort definitions remain visible and reproducible.

03

Keep the decision human

The output supports actuarial and underwriting judgement; it does not make a clinical or member-level decision.